| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology and Biochemistry, Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 [P. P. C., C. M. H., A. B., A. D. L., Y. F., A. G.]; Jefferson Cancer Institute and Thomas Jefferson University, Philadelphia Pennsylvania 19107 [G. C., B. C.] and Cell Biology Section, Laboratory of Viral Carcinogenesis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 [Y. S., N. C.]
The retinoblastoma tumor suppressor gene product, as well as its related protein p107, has been shown clearly to exert its growth suppressive effects in a cell cycle dependent manner. In this study we demonstrate that the introduction of our recently cloned Rb family member p130/pRb2 causes growth arrest in three tumor cell lines. In addition, in the nasopharyngeal carcinoma derived cell line HONE-1, we identified a low level of expression of p130/pRb2, possibly due to gene rearrangement, and a drastic reduction in proliferation upon introduction of a constitutive active p130/pRb2 complementary DNA clone. Furthermore, we were able to dissect distinct properties of the Rb family by demonstrating that p130/pRb2 inhibits proliferation of the glioblastoma cell line T98G, which is resistant to the growth suppressive effects of both pRb and p107. Our studies demonstrate that the Rb family proteins identified to date may complement each other but they are not fully functionally redundant.
1 A. D. L. is supported by a fellowship from the University of Bari (Dottorato di Ricerca in Morfologia Umana e Sperimentale). The work was supported by NIH Grant RO1 CA60999 and a grant from W. W. Smith to A. G. and American Cancer Society grants to B. C.
2 To whom requests for reprints should be addressed. Present address: Institute for Cancer Research and Molecular Medicine and Jefferson Cancer Institute, Thomas Jefferson University, Bluemle Life Sciences Bldg., 233 South 10th St., Philadelphia, PA 19107.
Received 9/16/94. Accepted 9/29/94.
This article has been cited by other articles:
![]() |
V. Masciullo, E. Berardengo, A. Boglione, A. Sgambato, A. Bernardi, M. Forni, A. Linari, L. Cito, G. Scambia, A. Comandone, et al. The Retinoblastoma Family Member pRb2/p130 Is an Independent Predictor of Survival in Human Soft Tissue Sarcomas Clin. Cancer Res., August 1, 2008; 14(15): 4775 - 4779. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Falco, E. Leucci, D. Lenze, P. P. Piccaluga, P. P. Claudio, A. Onnis, G. Cerino, J. Nyagol, W. Mwanda, C. Bellan, et al. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors Blood, August 15, 2007; 110(4): 1301 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coisy-Quivy, O. Disson, V. Roure, C. Muchardt, J.-M. Blanchard, and J.-C. Dantonel Role for brm in cell growth control. Cancer Res., May 15, 2006; 66(10): 5069 - 5076. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Russo, A. Zamparelli, C. M. Howard, C. Minimo, C. Bellan, G. Carillo, L. Califano, L. Leoncini, A. Giordano, and P. P. Claudio Expression of Cell Cycle-Regulated Proteins pRB2/p130, p107, E2F4, p27, and pCNA in Salivary Gland Tumors: Prognostic and Diagnostic Implications Clin. Cancer Res., May 1, 2005; 11(9): 3265 - 3273. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rodier, C. Makris, P. Coulombe, A. Scime, K. Nakayama, K. I. Nakayama, and S. Meloche p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2 J. Cell Biol., January 3, 2005; 168(1): 55 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Dannenberg, L. Schuijff, M. Dekker, M. van der Valk, and H. t. Riele Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130 Genes & Dev., December 1, 2004; 18(23): 2952 - 2962. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tonini, C. Gabellini, L. Bagella, G. D'Andrilli, V. Masciullo, G. Romano, G. Scambia, G. Zupi, and A. Giordano pRb2/p130 Decreases Sensitivity to Apoptosis Induced by Camptothecin and Doxorubicin but not by Taxol Clin. Cancer Res., December 1, 2004; 10(23): 8085 - 8093. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma Carcinogenesis, August 1, 2004; 25(8): 1485 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Andrilli, V. Masciullo, L. Bagella, T. Tonini, C. Minimo, G. F. Zannoni, R. L. Giuntoli II, J. A. Carlson Jr., D. R. Soprano, K. J. Soprano, et al. Frequent Loss of pRb2/p130 in Human Ovarian Carcinoma Clin. Cancer Res., May 1, 2004; 10(9): 3098 - 3103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Bellan, S Lazzi, G De Falco, A Nyongo, A Giordano, and L Leoncini Burkitt's lymphoma: new insights into molecular pathogenesis J. Clin. Pathol., March 1, 2003; 56(3): 188 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Helt and D. A. Galloway Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins Carcinogenesis, February 1, 2003; 24(2): 159 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bellan, G. De Falco, G. M. Tosi, S. Lazzi, F. Ferrari, G. Morbini, S. Bartolomei, P. Toti, P. Mangiavacchi, G. Cevenini, et al. Missing Expression of pRb2/p130 in Human Retinoblastomas Is Associated with Reduced Apoptosis and Lesser Differentiation Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3602 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputi, A. M. Groeger, V. Esposito, A. De Luca, V. Masciullo, A. Mancini, F. Baldi, E. Wolner, and A. Giordano Loss of pRb2/p130 Expression Is Associated with Unfavorable Clinical Outcome in Lung Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3850 - 3856. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Claudio, A. Zamparelli, F. U. Garcia, L. Claudio, G. Ammirati, A. Farina, A. Bovicelli, G. Russo, G. G. Giordano, D. E. McGinnis, et al. Expression of Cell-Cycle-regulated Proteins pRb2/p130, p107, p27kip1, p53, mdm-2, and Ki-67 (MIB-1) in Prostatic Gland Adenocarcinoma Clin. Cancer Res., June 1, 2002; 8(6): 1808 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ndolo, N. K. Dhillon, H. Nguyen, M. Guadalupe, M. Mudryj, and S. Dandekar Simian Immunodeficiency Virus Nef Protein Delays the Progression of CD4+ T Cells through G1/S Phase of the Cell Cycle J. Virol., March 19, 2002; 76(8): 3587 - 3595. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chestukhin, L. Litovchick, K. Rudich, and J. A. DeCaprio Nucleocytoplasmic Shuttling of p130/RBL2: Novel Regulatory Mechanism Mol. Cell. Biol., January 15, 2002; 22(2): 453 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ciarmatori, P. H. Scott, J. E. Sutcliffe, A. McLees, H. M. Alzuherri, J.-H. Dannenberg, H. te Riele, I. Grummt, R. Voit, and R. J. White Overlapping Functions of the pRb Family in the Regulation of rRNA Synthesis Mol. Cell. Biol., September 1, 2001; 21(17): 5806 - 5814. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Alexander and P. W. Hinds Requirement for p27KIP1 in Retinoblastoma Protein-Mediated Senescence Mol. Cell. Biol., June 1, 2001; 21(11): 3616 - 3631. [Abstract] [Full Text] |
||||
![]() |
M. G. Paggi and A. Giordano Who Is the Boss in the Retinoblastoma Family? The Point of View of Rb2/p130, the Little Brother Cancer Res., June 1, 2001; 61(12): 4651 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Claudio, P. Stiegler, C. M. Howard, C. Bellan, C. Minimo, G. M. Tosi, J. Rak, A. Kovatich, Paola De Fazio, P. Micheli, et al. RB2/p130 Gene-enhanced Expression Down-Regulates Vascular Endothelial Growth Factor Expression and Inhibits Angiogenesis in Vivo Cancer Res., January 1, 2001; 61(2): 462 - 468. [Abstract] [Full Text] |
||||
![]() |
J. W. Harbour and D. C. Dean The Rb/E2F pathway: expanding roles and emerging paradigms Genes & Dev., October 1, 2000; 14(19): 2393 - 2409. [Full Text] |
||||
![]() |
A. Amanullah, B. Hoffman, and D. A. Liebermann Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15INK4B and p16INK4A Blood, July 15, 2000; 96(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Howard, P. P. Claudio, Antonio De Luca, P. Stiegler, F. P. Jori, N. M. Safdar, M. Caputi, K. Khalili, and A. Giordano Inducible pRb2/p130 Expression and Growth-suppressive Mechanisms: Evidence of a pRb2/p130, p27Kip1, and Cyclin E Negative Feedback Regulatory Loop Cancer Res., May 1, 2000; 60(10): 2737 - 2744. [Abstract] [Full Text] |
||||
![]() |
P. P. Claudio, M. Caputi, and A. Giordano The RB2/p130 Gene: The Latest Weapon in the War against Lung Cancer? Clin. Cancer Res., March 1, 2000; 6(3): 754 - 764. [Abstract] [Full Text] |
||||
![]() |
P. P. Claudio, C. M. Howard, Y. Fu, C. Cinti, L. Califano, P. Micheli, E. W. Mercer, M. Caputi, and A. Giordano Mutations in the Retinoblastoma-related Gene RB2/p130 in Primary Nasopharyngeal Carcinoma Cancer Res., January 1, 2000; 60(1): 8 - 12. [Abstract] [Full Text] |
||||
![]() |
P. P. Claudio, C. M. Howard, C. Pacilio, C. Cinti, G. Romano, C. Minimo, N. M. Maraldi, J. D. Minna, L. Gelbert, L. Leoncini, et al. Mutations in the Retinoblastoma-related Gene RB2/p130 in Lung Tumors and Suppression of Tumor Growth in Vivo by Retrovirus-mediated Gene Transfer Cancer Res., January 1, 2000; 60(2): 372 - 382. [Abstract] [Full Text] |
||||
![]() |
C. Cinti, P. P. Claudio, C. M. Howard, L. M. Neri, Y. Fu, L. Leoncini, G. M. Tosi, N. M. Maraldi, and A. Giordano Genetic Alterations Disrupting the Nuclear Localization of the Retinoblastoma-related Gene RB2/p130 in Human Tumor Cell Lines and Primary Tumors Cancer Res., January 1, 2000; 60(2): 383 - 389. [Abstract] [Full Text] |
||||
![]() |
L. Leoncini, C. Bellan, A. Cossu, P. P. Claudio, S. Lazzi, C. Cinti, G. Cevenini, T. Megha, L. Laurini, P. Luzi, et al. Retinoblastoma-related p107 and pRb2/p130 Proteins in Malignant Lymphomas: Distinct Mechanisms of Cell Growth Control Clin. Cancer Res., December 1, 1999; 5(12): 4065 - 4072. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Claudio, L. Fratta, F. Farina, C. M. Howard, G. Stassi, S.-i. Numata, C. Pacilio, A. Davis, M. Lavitrano, M. Volpe, et al. Adenoviral RB2/p130 Gene Transfer Inhibits Smooth Muscle Cell Proliferation and Prevents Restenosis After Angioplasty Circ. Res., November 26, 1999; 85(11): 1032 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Sutcliffe, C. A. Cairns, A. McLees, S. J. Allison, K. Tosh, and R. J. White RNA Polymerase III Transcription Factor IIIB Is a Target for Repression by Pocket Proteins p107 and p130 Mol. Cell. Biol., June 1, 1999; 19(6): 4255 - 4261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Massaro-Giordano, G. Baldi, A. De Luca, A. Baldi, and A. Giordano Differential Expression of the Retinoblastoma Gene Family Members in Choroidal Melanoma: Prognostic Significance Clin. Cancer Res., June 1, 1999; 5(6): 1455 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Ravi, A. Thiagalingam, E. Weber, M. McMahon, B. D. Nelkin, and M. Mabry Raf-1 Causes Growth Suppression and Alteration of Neuroendocrine Markers in DMS53 Human Small-Cell Lung Cancer Cells Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 543 - 549. [Abstract] [Full Text] |
||||
![]() |
M. Caputi, A. M. Groeger, V. Esposito, C. Dean, A. De Luca, C. Pacilio, M. R. Muller, G. G. Giordano, F. Baldi, E. Wolner, et al. Prognostic Role of Cyclin D1 in Lung Cancer . Relationship to Proliferating Cell Nuclear Antigen Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 746 - 750. [Abstract] [Full Text] |
||||
![]() |
S. Wang, R. N. Ghosh, and S. P. Chellappan Raf-1 Physically Interacts with Rb and Regulates Its Function: a Link between Mitogenic Signaling and Cell Cycle Regulation Mol. Cell. Biol., December 1, 1998; 18(12): 7487 - 7498. [Abstract] [Full Text] |
||||
![]() |
N. S. B. Thomas, A. R. Pizzey, S. Tiwari, C. D. Williams, and J. Yang p130, p107, and pRb Are Differentially Regulated in Proliferating Cells and during Cell Cycle Arrest by alpha -Interferon J. Biol. Chem., September 11, 1998; 273(37): 23659 - 23667. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Robanus-Maandag, M. Dekker, M. van der Valk, M.-L. Carrozza, J.-C. Jeanny, J.-H. Dannenberg, A. Berns, and H. te Riele p107 is a suppressor of retinoblastoma development in pRb-deficient mice Genes & Dev., June 1, 1998; 12(11): 1599 - 1609. [Abstract] [Full Text] |
||||
![]() |
B. H. Lee, M. Liu, and M. B. Mathews Regulation of the Human Proliferating Cell Nuclear Antigen Promoter by the Adenovirus E1A-Associated Protein p107 J. Virol., February 1, 1998; 72(2): 1138 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Mulligan, J. Wong, and T. Jacks p130 Is Dispensable in Peripheral T Lymphocytes: Evidence for Functional Compensation by p107 and pRB Mol. Cell. Biol., January 1, 1998; 18(1): 206 - 220. [Abstract] [Full Text] |
||||
![]() |
W. R. Sellers, B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. Kaelin Jr. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth Genes & Dev., January 1, 1998; 12(1): 95 - 106. [Abstract] [Full Text] |
||||
![]() |
P. J. Hauser, D. Agrawal, B. Chu, and W. J. Pledger p107 and p130 Associated Cyclin A Has Altered Substrate Specificity J. Biol. Chem., September 5, 1997; 272(36): 22954 - 22959. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Helin, K. Holm, A. Niebuhr, H. Eiberg, N. Tommerup, S. Hougaard, H. S. Poulsen, M. Spang-Thomsen, and P. Norgaard Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma PNAS, June 24, 1997; 94(13): 6933 - 6938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cooper, M. Lippa, J. M. Payne, G. Hatzivassiliou, E. Reifenberg, B. Fayazi, J. C. Perales, L. J. Morrison, D. Templeton, R. L. Piekarz, et al. Safety-modified episomal vectors for human gene therapy PNAS, June 10, 1997; 94(12): 6450 - 6455. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Allen, S de la Luna, R. Kerkhoven, R Bernards, and N. La Thangue Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors J. Cell Sci., January 11, 1997; 110(22): 2819 - 2831. [Abstract] [PDF] |
||||
![]() |
A. Sala, A. De Luca, A. Giordano, and C. Peschle The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity J. Biol. Chem., November 15, 1996; 271(46): 28738 - 28740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M H Lee, B O Williams, G Mulligan, S Mukai, R T Bronson, N Dyson, E Harlow, and T Jacks Targeted disruption of p107: functional overlap between p107 and Rb. Genes & Dev., July 1, 1996; 10(13): 1621 - 1632. [Abstract] [PDF] |
||||
![]() |
D Cobrinik, M H Lee, G Hannon, G Mulligan, R T Bronson, N Dyson, E Harlow, D Beach, R A Weinberg, and T Jacks Shared role of the pRB-related p130 and p107 proteins in limb development. Genes & Dev., July 1, 1996; 10(13): 1633 - 1644. [Abstract] [PDF] |
||||
![]() |
A. Sala, I. Casella, T. Bellon, B. Calabretta, R. J. Watson, and C. Peschle B-myb Promotes S Phase and Is a Downstream Target of the Negative Regulator p107 in Human Cells J. Biol. Chem., April 19, 1996; 271(16): 9363 - 9367. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chen, C. T. Guy, H.-W. Chen, N. Hu, E. Y.-H. P. Lee, and W.-H. Lee Molecular Cloning and Developmental Expression of Mouse p130, a Member of the Retinoblastoma Gene Family J. Biol. Chem., April 19, 1996; 271(16): 9567 - 9572. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yuan, G. Condorelli, M. Caruso, A. Felsani, and A. Giordano Human p300 Protein Is a Coactivator for the Transcription Factor MyoD J. Biol. Chem., April 12, 1996; 271(15): 9009 - 9013. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, F. Rossi, W. Fang, T. Mori, and D. Cobrinik Cdk2-dependent Phosphorylation and Functional Inactivation of the pRB-related p130 Protein in pRB(-), p16INK4A(+) Tumor Cells J. Biol. Chem., September 22, 2000; 275(39): 30317 - 30325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashizawa, H. Nishizawa, M. Yamada, H. Higashi, T. Kondo, H. Ozawa, A. Kakita, and M. Hatakeyama Collective Inhibition of pRB Family Proteins by Phosphorylation in Cells with p16INK4a Loss or Cyclin E Overexpression J. Biol. Chem., March 30, 2001; 276(14): 11362 - 11370. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murai, Y. Nakagawa, H. Maeda, and K. Terada Altered Regulation of Cell Cycle Machinery Involved in Interleukin-1-induced G1 and G2 Phase Growth Arrest of A375S2 Human Melanoma Cells J. Biol. Chem., February 23, 2001; 276(9): 6797 - 6806. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |